Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
Clinical trial NCT01802333 · COMPLETED
Trial details
- NCT number
- NCT01802333
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-12
- Primary completion
- 2017-06-15
- Enrollment
- 754
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.